Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 24
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06782594 | A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction | ||
| NCT05076474 | Pharmacodynamic Equivalence Study Of Orlistat Capsules 60 mg | ||
| NCT06819774 | Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria | ||
| NCT04457830 | The Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL). | ||
| NCT06783257 | Phase II Clinical Study of Vonorasan Fumarate Injection in the Treatment of Peptic Ulcer Bleeding | ||
| NCT06226363 | Phase I Study of LNF1901 in Advanced Malignant Tumors | ||
| NCT04984434 | Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple Myeloma | ||
| NCT04457869 | A Study of F520 in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Secondary Central Nervous System Lymphoma (SCNSL) | ||
| NCT06226350 | A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma | ||
| NCT06722950 | Phase II Clinical Study of AC591 in Preventing Oxaliplatin-Induced Peripheral Neuropathy | ||
| NCT05178836 | A Phase II Study to Evaluate the Efficacy and Safety of F520 Combined With F007 in Patients With RR DLBCL | ||
| NCT05040906 | A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients | ||
| NCT03657381 | Phase Ⅰ Study to Evaluate the Safety and Tolerability of Using F520 | ||
| NCT06206915 | Phase I Study of XZ120 in Malignant Tumors | ||
| NCT06755515 | A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer | ||
| NCT05740215 | Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors | ||
| NCT05741021 | A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT05408221 | the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma | ||
| NCT04636515 | A Phase Ⅱ Study of F520 in Patients With Urothelial Carcinoma | ||
| NCT06202456 | A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver | ||
| NCT06188611 | A Phase IV Study of Huazhi Rougan Granule | ||
| NCT05305183 | A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis | ||
| NCT05293028 | Study of F527 in Patients With Relapsed or Refractory Lymphoma | ||
| NCT06752447 | A Phase I Study OfLNF2007 Monotherapy in Patients with Advanced Solid Tumors |
